Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

6 September 2017

Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer,
Advancing Leadership in Immuno-Oncology. More

4 June 2017

F-star Expands its Relationship with Merck through a new Strategic Collaboration to Develop Bispecific Antibodies in Immuno-Oncology. More

3 May 2017

Rigontec Starts First-In-Human, Phase I/II Trial of RIG-I Agonist
RGT100 and Appoints Eugen Leo as Chief Medical Officer. More

25 April 2017

Forge Therapeutics Raises $15M Series A Financing to Develop First Novel Gram-Negative Antibiotic In Decades More

13 February 2017

miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing More

3 November 2016

miRagen Therapeutics Announces Presentation of MRG-106 Clinical Data at American Society of Hematology Annual Meeting More

 

 

Featured Portfolio